Axel Rominger wetenschapper
Rominger, Axel 1977-
VIAF ID: 317280947 (Personal)
Permalink: http://viaf.org/viaf/317280947
Preferred Forms
- 100 0 _ ‡a Axel Rominger ‡c wetenschapper
- 100 1 _ ‡a Rominger, Axel ‡d 1977-
- 100 1 _ ‡a Rominger, Axel ‡d 1977-
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
[18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy. | |
Functional disturbance of the locomotor network in progressive supranuclear palsy | |
[Hereditary diffuse leukencephalopathy with spheroids: a microgliopathy due to CSF1 receptor impairment]. | |
High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging. | |
Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects | |
Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT | |
Identification of a rare presenilin 1 single amino acid deletion mutation (F175del) with unusual amyloid-β processing effects | |
Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy | |
IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation | |
Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study | |
Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation | |
Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET. | |
Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI | |
Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction | |
In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. | |
Incidental SARS-CoV-2-related findings in asymptomatic patients in [18F]-FDG-PET/CT-potential insights | |
Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia | |
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial | |
Laquinimod ameliorates secondary brain inflammation | |
Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau | |
Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET. | |
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model | |
Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning | |
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE | |
Lymphedema of the upper limb: evaluation of the functional outcome by dynamic imaging of lymph kinetics after autologous lymph vessel transplantation | |
Magnetic resonance imaging versus lymphoscintigraphy for the assessment of focal lymphatic transport disorders of the lower limb: first experiences. | |
Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects | |
Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson's disease: a longitudinal study | |
Metabolic patterns across core features in dementia with lewy bodies | |
Metastatic mammary carcinoma despite histologically negative sentinel lymph nodes: are there any indicators for estimating recurrence and metastasis rates? | |
Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study | |
[Microsurgical Autologous Lymph Vessel Transplantation: Does Harvesting Lymphatic Vessel Grafts Induce Lymphatic Transport Disturbances in the Donor Limb?]. | |
Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex. | |
Modulation of K+-evoked [3H]-noradrenaline release from rat and human brain slices by gabapentin: involvement of KATP channels | |
Monitoring of chronic γ-secretase modulator treatment by serial amyloid-PET. | |
Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches | |
Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of Parkinsonism | |
Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. | |
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System | |
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease | |
A novel image signature-based radiomics method to achieve precise diagnosis and prognostic stratification of gliomas | |
Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism. | |
[A Pair of Siblings with a rare R5H-Mutation in Exon 1 of the MAPT-Gene]. | |
Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET. | |
Perfusion-Phase [18F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration | |
PET and SPECT in epilepsy: a critical review. | |
PET/CT imaging of atherosclerotic blood vessel alterations | |
PET imaging in extratemporal epilepsy requires consideration of electroclinical findings. | |
PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes | |
[Posterior cortical atrophy-a heterogeneous syndrome : A case series] | |
Postinfectious Opsoclonus-Myoclonus Syndrome in a 41-Year-Old Patient-Visualizing Hyperactivation in Deep Cerebellar Nuclei by Cerebral [(18) F]-FDG- PET. | |
Postural imbalance and falls in PSP correlate with functional pathology of the thalamus. | |
Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET. | |
Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer | |
Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment | |
Primary lymphedema of the lower limb: the clinical utility of single photon emission computed tomography/CT | |
[Prostate-specific membrane antigen (PSMA)-based diagnostics and treatment of prostate cancer] | |
PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomography | |
PSMA-negative prostate cancer and the continued value of choline-PET/CT | |
PSMA radioligand therapy in prostate cancer: overview, latest advances and remaining challenges | |
Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT. | |
Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease | |
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? | |
Radiologische Diagnostik des CUP-Syndroms | |
Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy | |
Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials | |
Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison | |
Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects | |
Reduced Periprocedural Analgesia After Replacement of Water for Injection with Glucose 5% Solution as the Infusion Medium for 90Y-Resin Microspheres | |
Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden | |
Regional gray matter-dedicated SUVR with 3D-MRI detects positive amyloid deposits in equivocal amyloid PET images | |
Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment. | |
The relevance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in diagnosing prosthetic graft infections post cardiac and proximal thoracic aortic surgery | |
Renal volume assessed by magnetic resonance imaging volumetry correlates with renal function in living kidney donors pre- and postdonation: a retrospective cohort study | |
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia | |
Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms | |
Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models | |
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers | |
Surrogate markers for cerebral blood flow correlate with [¹⁸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum. | |
A Survey of Molecular Imaging of Opioid Receptors | |
Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease. | |
Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life Span of Wild-Type Mice: A PET Study. | |
Towards guidelines to harmonize textural features in PET: Haralick textural features vary with image noise, but exposure-invariant domains enable comparable PET radiomics | |
Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors. | |
Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar | |
Validation of the octamouse for simultaneous 18F-fallypride small-animal PET recordings from 8 mice | |
Vessel Wall Inflammation in Spontaneous Cervical Artery Dissection | |
Wirkung von Nociceptin, Orphanin FQ auf die [3H]-Noradrenalin-Freisetzung im Neocortex des Menschen und der Ratte | |
WORD RETRIEVAL IN PRIMARY PROGRESSIVE APHASIA FOLLOWING LANGUAGE THERAPY | |
α2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse |